Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section
Senthil Sadhasivam · with National Center for Advancing Translational Sciences (NCATS) · NCT05380531
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 700
- US sites recruiting
- 3
- Study start
- December 5, 2022
- Record last updated
- September 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this collaborative CTSA (Clinical and Translational Science Award) application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in breastfeeding mothers and their infants
Being studied: Preoperative Genotyping
Conditions: Cesarean Section Complications; Opioid Use
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Adult women (>18 yr) All races American Society of Anesthesiologists Classification (ASA) physical status: 1 to 3 undergoing elective Cesarean section that are willing to receive in-patient opioids.
Exclusion Criteria
- Health conditions including uncontrolled diabetes (gestational or pre-existing) or hypertension (pre-eclampsia, eclampsia, or chronic)
- Any history of opioid misuse before or during pregnancy-per self-report and clinical notes
- Preoperative severe pain and opioid use/misuse, allergy to oxycodone
- Allergy to oxycodone
- Significant neurological disorders, liver and renal diseases
Recruiting US locations
Riley Children's Hospital- Clinics / Labor and Delivery Unit
Indianapolis, IN 46202
Site contact: David M. Haas, MD · 317-880-3960 · dahaas@iu.edu
Washington University Hospital
St Louis, MO 63110
Site contact: Arvind Palanisamy, MD · 314-362-2330 · arvind.palanisamy@wustl.edu
University of Pittsburgh
Pittsburgh, PA 15260
Site contact: Amy Monroe, MPH · 412-623-6382 · monroeal@upmc.edu
Study contacts (from the official record)
- Senthilkumar Sadhasivam, MD, MPH · 4126472994 · sadhasivams@upmc.edu
- Dayana Alsamsam, MPH · alsamsamd@upmc.edu
Similar studies in Indiana
All pregnancy studies in Indiana →- RecruitingPhase 3
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Aerogen Pharma Limited
- Location
- South Bend, IN + 17 other US sites
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteersPhase 2
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Mayo Clinic
- Location
- Indianapolis, IN + 3 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingHealthy volunteers
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Yale University
- Location
- Indianapolis, IN + 32 other US sites
- Eligibility basics
- Ages 15–55 · Women only
- RecruitingHealthy volunteers
Maternal Newborn Health Registry
NICHD Global Network for Women's and Children's Health
- Location
- Indianapolis, IN + 7 other US sites
- Eligibility basics
- Any age listed